Zobrazeno 1 - 10
of 432
pro vyhledávání: '"Lawrence Sher"'
Autor:
Joseph Fowler, Jeffrey Sugarman, Lawrence Sher, Chuanbo Zang, John L. Werth, Daniela E. Myers, Daniela Graham, Alexander Agyei Marfo, Liza Takiya
Publikováno v:
Dermatology and Therapy, Vol 13, Iss 4, Pp 951-960 (2023)
Plain Language Summary Atopic dermatitis (AD), also known as eczema, is a chronic skin disease that causes red or flaky skin patches that can become infected and itch. Children with AD often experience sleep disturbance, including difficulty falling
Externí odkaz:
https://doaj.org/article/9f3154ed08464b0a9bf4d464568f6ef9
Publikováno v:
Tennessee Tribune; 5/18/2023, Vol. 34 Issue 20, pB1-B1, 1/3p
Autor:
Mario Castro, Edward Kerwin, David Miller, Andrew Pedinoff, Lawrence Sher, Pamela Cardenas, Barbara Knorr, David Lawrence, Diego Ossa, Wei Wang, Jorge F Maspero
Publikováno v:
EClinicalMedicine, Vol 35, Iss , Pp 100847- (2021)
Background: These studies assessed the efficacy and safety of fevipiprant, an oral antagonist of the prostaglandin D2 (PGD2) receptor (DP2), compared with placebo when added to standard-of-care (SoC) asthma therapy in patients with uncontrolled asthm
Externí odkaz:
https://doaj.org/article/9701c3aea1214afcb299268838d8fcc0
Autor:
Amy S Paller, Eric L Simpson, Elaine C Siegfried, Michael J Cork, Andreas Wollenberg, Peter D Arkwright, Weily Soong, Mercedes E Gonzalez, Lynda C Schneider, Robert Sidbury, Benjamin Lockshin, Steven Meltzer, Zhixiao Wang, Leda P Mannent, Nikhil Amin, Yiping Sun, Elizabeth Laws, Bolanle Akinlade, Myles Dillon, Matthew P Kosloski, Mohamed A Kamal, Ariane Dubost-Brama, Naimish Patel, David M Weinreich, George D Yancopoulos, John T O’Malley, Ashish Bansal, Amber Pepper, David Cohen, David Pariser, Jeffrey Leflein, Jeffrey Weinberg, John Browning, Joyce Teng, Lara Wine Lee, Lawrence Sher, Lucia Diaz, Lynda Schneider, Ned Rupp, Peck Ong, Robert Cartwright, Andreas Pinter, Christina Schnopp, Anna Korkosz, Dorota Bystrzanowska, Ewa Sygula, Jacek Zdybski, Kamila Padlewska
Publikováno v:
The Lancet. 400:908-919
Current systemic treatments for children younger than 6 years with moderate-to-severe atopic dermatitis that is uncontrolled with topical therapies might have suboptimal efficacy and safety. Dupilumab is approved for older children and adults with at
Autor:
Sher, Lawrence
Publikováno v:
American Cinematographer; Jan2021, Vol. 102 Issue 1, p80-80, 1p, 1 Color Photograph
Autor:
Nami Pandit-Abid, Camille Taillé, Lauren Cohn, Lawrence Sher, Asif H. Khan, Giovanni Passalacqua, Yi Zhang, Santiago Quirce, Benjamin Ortiz, Nadia Daizadeh
Publikováno v:
62. Kongress der Deutschen Gesellschaft für Pneumologie und Beatmungsmedizin e. V..
Publikováno v:
Journal of Allergy and Clinical Immunology. 151:AB148
Autor:
Namrata Pandit-Abid, Benjamin Ortiz, Nadia Daizadeh, Jorge Maspero, Michael E. Wechsler, Elizabeth Laws, David J. Lederer, Leda Mannent, Lawrence Sher, Marcella Ruddy, Klaus F. Rabe, Megan Hardin, Xuezhou Mao
Publikováno v:
Chest. 160:A1882-A1884
Autor:
Heribert Staudinger, Marcella Ruddy, Yamo Deniz, Naimish Patel, Jonathan Corren, Paul Rowe, Ariel Teper, David Langton, Neil M.H. Graham, Lawrence Sher, Ian D. Pavord, Megan S. Rice, Salman Siddiqui, Philip G. Bardin, Hae-Sim Park, Alberto Papi
Publikováno v:
Journal of Asthma and Allergy. 13:701-711
Purpose The Phase 3 LIBERTY ASTHMA QUEST study in patients aged ≥12 years with uncontrolled, moderate-to-severe asthma demonstrated the efficacy and safety of dupilumab 200 mg and 300 mg every 2 weeks (q2w) vs matched placebo in the overall populat
Autor:
Anil, Gupta, Yaneicy, Gonzalez-Rojas, Erick, Juarez, Manuel, Crespo Casal, Jaynier, Moya, Diego, Rodrigues Falci, Elias, Sarkis, Joel, Solis, Hanzhe, Zheng, Nicola, Scott, Andrea L, Cathcart, Sergio, Parra, Jennifer E, Sager, Daren, Austin, Amanda, Peppercorn, Elizabeth, Alexander, Wendy W, Yeh, Cynthia, Brinson, Melissa, Aldinger, Adrienne E, Shapiro, Lawrence, Sher
Publikováno v:
JAMA
IMPORTANCE: Older patients and those with comorbidities who are infected with SARS-CoV-2 may be at increased risk of hospitalization and death. Sotrovimab is a neutralizing antibody for the treatment of high-risk patients to prevent COVID-19 progress